MARKET

TLPH

TLPH

Talphera Inc
NASDAQ
0.9300
+0.0288
+3.20%
Closed 16:00 07/12 EDT
OPEN
0.9099
PREV CLOSE
0.9012
HIGH
0.9400
LOW
0.8900
VOLUME
47.19K
TURNOVER
0
52 WEEK HIGH
1.610
52 WEEK LOW
0.4250
MARKET CAP
15.80M
P/E (TTM)
-1.0493
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TLPH last week (0701-0705)?
Weekly Report · 6d ago
Weekly Report: what happened at TLPH last week (0624-0628)?
Weekly Report · 07/01 12:01
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Syntec Optics stock is rocketing more than 248% after securing a key patent in Europe. The biggest pre-market stock movers on Wednesday morning are patent news, a new investment, proposed public offerings and more. Check out the top 10 moving stocks this morning.
Investorplace · 06/26 11:41
Talphera Shareholders Affirm Leadership and Financial Strategy
TipRanks · 06/24 22:53
Weekly Report: what happened at TLPH last week (0617-0621)?
Weekly Report · 06/24 12:11
12 Health Care Stocks Moving In Thursday's After-Market Session
Psyence Biomedical stock moved upwards by 68.1% to $1.0 during Thursday's after-market session. Kintara Therapeutics (NASDAQ:KTRA) shares rose by 15.67% during the session. Clover Health Investments and Helius Medical Tech were among the day's gainers.
Benzinga · 06/20 20:31
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Thursday. SMX (Security Matters) stock is rocketing more than 100% alongside heavy pre-market trading. Study data, acquisition updates, a secondary stock offering and more are moving stocks this morning. 10 Top Gainers: SMX stock is soaring over 50% with new study data.
Investorplace · 06/20 11:28
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Nexalin Technology (NASDAQ:NXL) stock increased by 48.1% to $1.54 during Wednesday's after-market session. Tempest Therapeutics ( NASDAQ:TPST) stock moved upwards by 40.0% during the session. ASLAN Pharma (NASdaq:ASLN) shares increased by 18.51%.
Benzinga · 06/19 20:30
More
About TLPH
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for use in medically supervised settings. The Company’s nafamostat product candidates include Niyad and LTX-608. Niyad is focused on developing regional anticoagulants for injection into the extracorporeal circuit, such as the dialysis circuit during continuous renal replacement therapy (CRRT) for acute kidney injury (AKI) patients in the hospital, and for chronic kidney disease patients undergoing intermittent hemodialysis (IHD) in dialysis centers. LTX-608 is its nafamostat formulation for direct intravenous (IV) infusion being explored as an investigational product for the antiviral treatment of COVID, acute respiratory distress syndrome (ARDS) disseminated intravascular coagulation (DIC), and acute pancreatitis. Its pre-filled syringe product candidates include Fedsyra and Phenylephrine.

Webull offers Talphera Inc stock information, including NASDAQ: TLPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLPH stock methods without spending real money on the virtual paper trading platform.